✦ LIBER ✦

Multiple sclerosis poses tough drug development challenges

✍ Scribed by Kathryn Senior

Book ID: 114385260
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 114 KB
Volume: 10
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(05)03658-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Developing drugs for multiple sclerosis

✍ Janet Fricker 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 17 KB

Recent developments in drug therapy for

Recent developments in drug therapy for multiple sclerosis

✍ Smith, P. F; Darlington, C. L 📂 Article 📅 1999 🏛 SAGE Publications 🌐 English ⚖ 177 KB

Fingolimod (FTY720): discovery and devel

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

✍ Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmoude 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Fingolimod (FTY720): discovery and devel

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

✍ Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmoude 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 649 KB

“Hinge” peptide libraries in basic resea

“Hinge” peptide libraries in basic research and drug development: Application to breast cancer and multiple sclerosis

✍ Graham J. Moore 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Libraries of peptides in which a centrally located linker group is introduced to deliberately disrupt the ordered backbone structure and allow the flanking amino acid sidechains to cluster together are called "hinge" or "hairpin" peptide libraries. Screening of these libraries with bioassays directe

ChemInform Abstract: “Hinge” Peptide Lib

ChemInform Abstract: “Hinge” Peptide Libraries in Basic Research and Drug Development: Application to Breast Cancer and Multiple Sclerosis

✍ G. J. MOORE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB